Bottom line
Is WDNA a good fund? The bottom line
WDNA is an actively managed large blend ETF from WisdomTree.
It charges 0.45% — about $45 a year on every $10,000 invested, cheaper than 81% of large blend funds we track.
It returned +22.9% over one year (as of Dec 31, 2025, per its prospectus).
With $2.7 million in net assets and 81 holdings, its largest position is Twist Bioscience Corp (5.9%) and the top 10 make up 30.7% of the portfolio.
What stands out
- Low cost: cheaper than 81% of large blend peers
What to watch
- Small fund ($2.7 million) — small funds are likelier to close
Updated Nov 19, 2026
What WDNA invests in
The WisdomTree BioRevolution Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (the Index).
The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return, and other characteristics resemble the risk, return, and other characteristics of the Index as a whole. The Fund invests, under normal circumstances, at least 80% of its net assets, plus any borrowings for investment purposes, in constituents of the Index and/or investments that have economic characteristics that are substantially similar to the economic characteristics of such constituents. WisdomTree, Inc. (WisdomTree), the index provider (the Index Provider) and parent company of the Funds investment adviser, WisdomTree Asset Management, Inc. (WisdomTree Asset Management or the…
From the fund's prospectus (filed Oct 28, 2026).
WDNA performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| WDNA | +22.9% | — | — |
| Large Blend median | +13.8% | +9.7% | +10.9% |
Source: Fund prospectus, as of Dec 31, 2025
What WDNA costs
On a $10,000 investment, WDNA's 0.45% expense ratio costs about $45 a year. The prospectus estimates $567 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
WDNA top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Twist Bioscience Corp TWST | 5.95% |
| 2 | Moderna Inc MRNA | 4.14% |
| 3 | Eli Lilly & Company LLY | 4.08% |
| 4 | Johnson & Johnson JNJ | 2.97% |
| 5 | United Therapeutics Corp UTHR | 2.45% |
| 6 | Natera Inc NTRA | 2.32% |
| 7 | Tempus Ai Inc TEM | 2.28% |
| 8 | Immunome Inc IMNM | 2.26% |
| 9 | Structure Therapeutics Inc GPCR | 2.11% |
| 10 | Stoke Therapeutics Inc STOK | 2.09% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 30.7% of the fund. See all top 25 holdings and asset mix →